Mon, June 27, 2022
Fri, June 24, 2022
Thu, June 23, 2022

Etzer Darout Initiated (YMAB) at Buy and Held Target at $27 on, Jun 24th, 2022

Etzer Darout of BMO Capital, Initiated "Y-mAbs Therapeutics, Inc." (YMAB) at Buy and Held Target at $27 on, Jun 24th, 2022.

Etzer has made no other calls on YMAB in the last 4 months.



There is 1 other peer that has a rating on YMAB. Out of the 1 peers that are also analyzing YMAB, 0 agree with Etzer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Etzer


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $63 on, Monday, February 28th, 2022